Serum leptin levels during pregnancy in multiple sclerosis.

Area of Science:

• Immunology
• Endocrinology
• Neuroscience

Background:

• Multiple sclerosis (MS) disease activity decreases during pregnancy and increases postpartum.
• The immuno-endocrinological mechanisms driving these MS activity fluctuations are not fully understood.
• Leptin, a hormone known to modulate inflammatory activity, is a potential mediator.

Purpose of the Study:

• To compare pregnancy-induced serum leptin level fluctuations in women with MS versus healthy controls.
• To determine if serum leptin levels correlate with periods of altered disease activity in MS patients.

Main Methods:

• Prospective follow-up of women with MS and healthy controls during and after pregnancy.
• Measurement of serum leptin and soluble leptin receptor (SLR) levels using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• Pre-pregnancy leptin levels were comparable between groups.
• Leptin levels increased in the third trimester for both MS patients and controls.
• A significant drop in leptin levels was observed postpartum in both groups, more pronounced in MS patients.
• Higher relative decreases in postpartum leptin levels were associated with increased postpartum relapse rates in MS patients.

Conclusions:

• Leptin levels rise during late pregnancy in women with MS.
• A common postpartum decline in leptin occurs in both MS patients and controls.
• The magnitude of the postpartum leptin decrease is linked to the risk of postpartum relapse in multiple sclerosis.